Bicara Therapeutics Inc. Common Stock (BCAX) — Defensive Interval Ratio
Bicara Therapeutics Inc. Common Stock (BCAX) has a Defensive Interval Ratio of 2007 days as of March 2026. Defensive assets of $216.29 Million (cash $-, short-term investments $216.29 Million, receivables $-) cover 2007 days of daily cash needs of $107.78K/day. See working capital position of Bicara Therapeutics Inc. Common Stock to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Bicara Therapeutics Inc. Common Stock Defensive Interval Ratio (2024–2025)
This chart shows how Bicara Therapeutics Inc. Common Stock's Defensive Interval Ratio has evolved across 2 annual periods from 2024 to 2025. As of March 2026, the ratio stands at 2007 days, meaning defensive assets of $216.29 Million can fund 2007 days of operations without new revenue. See Bicara Therapeutics Inc. Common Stock balance sheet quality to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Bicara Therapeutics Inc. Common Stock (2024–2025)
The table below presents the year-by-year Defensive Interval Ratio for Bicara Therapeutics Inc. Common Stock from 2024 to 2025, covering 2 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see market cap of Bicara Therapeutics Inc. Common Stock.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 4011 days | $318.12 Million | $79.31K/day | $- | $318.12 Million | ▲ +4011 days |
| 2024 | 0 days | $0.00 | $49.29K/day | $- | $0.00 | — |